Exploratory End Points News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exploratory End Points. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exploratory End Points Today - Breaking & Trending Today

Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes

Published: October 3, 2023

This study examines the efficacy and safety of tirzepatide vs insulin lispro adjunctive therapy to insulin glargine among those receiving basal insulin with ina

Source: jamanetwork.com

Related Topics:

Eteläuomen LäiUnited StatesCzech RepublicEli LillyJulio RosenstockEuropean Association For The Study Of DiabetesScientific Sessions Of The American Diabetes AssociationNovo NordiskBoehringer IngelheimVelocity Clinical Research At Medical CityGood ClinicalSize CalculationSecondary OutcomesExploratory End PointsVelocity Clinical ResearchMedical CityInterest DisclosuresApplied TherapeuticsBiomea FusionScholar RockStructure TherapeuticsTerns PharmaCarmot TherapeuticsScientific SessionsAmerican Diabetes Association

Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension

Published: September 10, 2023

This randomized clinical trial assesses the effect of 5 dosages of lorundrostat treatment vs placebo on 8-week systolic blood pressure change among adults with

Source: jamanetwork.com

Related Topics:

United StatesCatalys PacificStevene NissenNovo NordiskGroup InformationGordy HealthBristol Myers SquibbLucidact HealthClinical ResearchBoehringer IngelheimTanabe PharmaceuticalsAmerican Heart Association Hypertension Scientific SessionsInstitute IncAmsterdam PharmaceuticalsCleveland Clinic Coordinating CenterBetween JulyPatients With Uncontrolled HypertensionBend PointsSize CalculationAfrican AmericanEnd PointExploratory End PointsBiomarker End PointsMitsubishi Tanabe PharmaceuticalsCleveland Clinic